Cor Vasa 2014, 56(3):353-355 | DOI: 10.33678/cor.2014.023

Trandolapril je vhodnou volbou u hypertoniků s metabolickým syndromem či s rizikem rozvoje diabetu a u pacientů se srdečním selháním po infarktu myokardu

MUDr. Zuzana Zafarová

Published: June 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zafarová Z. Trandolapril je vhodnou volbou u hypertoniků s metabolickým syndromem či s rizikem rozvoje diabetu a u pacientů se srdečním selháním po infarktu myokardu. Cor Vasa. 2014;56(3):353-355. doi: 10.33678/cor.2014.023.
Download citation




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.